A Morabito|E Marubini - JoVE Visualize

Showing results (161-170 of 329) with videos related to

Pageof 33

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000

Time-dependent relevance of steroid receptors in breast cancerD Coradini, M G Daidone, P Boracchi, et al.

Journal of the National Cancer Institute|January 4, 1995

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent eventsU Veronesi, E Marubini, M Del Vecchio, et al.

Tumori|October 31, 1983

Prognostic factors in operable breast cancerB Salvadori, M Greco, C Clemente, et al.

European Journal of Cancer (Oxford, England : 1990)|December 16, 1998

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancerL Mariani, B Salvadori, E Marubini, et al.

Minerva Medica|June 30, 1983

[Behavior of serum immunoglobulins in boutonneuse fever]N Foti, A Morabito, A Masseo, et al.

Pediatric Surgery International|July 6, 2006

Wall or machine suction rectal biopsy for Hirschsprung's disease: a simple modified technique can improve the adequacy of biopsyA E Ali, J A Morecroft, J C Bowen, et al.

Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001

Thalidomide: an old sedative-hypnotic with anticancer activity?G Gasparini, A Morabito, E Magnani, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakiaG De Palo, U Veronesi, E Marubini, et al.

British Journal of Haematology|October 1, 1994

Cytosine arabinoside (Ara-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimensG Palmieri, A Morabito, A Rea, et al.

Pageof 33

Showing results (161-170 of 329) with videos related to

Sort By:

Pageof 33

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000

Time-dependent relevance of steroid receptors in breast cancerD Coradini, M G Daidone, P Boracchi, et al.

Journal of the National Cancer Institute|January 4, 1995

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent eventsU Veronesi, E Marubini, M Del Vecchio, et al.

Tumori|October 31, 1983

Prognostic factors in operable breast cancerB Salvadori, M Greco, C Clemente, et al.

European Journal of Cancer (Oxford, England : 1990)|December 16, 1998

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancerL Mariani, B Salvadori, E Marubini, et al.

Minerva Medica|June 30, 1983

[Behavior of serum immunoglobulins in boutonneuse fever]N Foti, A Morabito, A Masseo, et al.

Pediatric Surgery International|July 6, 2006

Wall or machine suction rectal biopsy for Hirschsprung's disease: a simple modified technique can improve the adequacy of biopsyA E Ali, J A Morecroft, J C Bowen, et al.

Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001

Thalidomide: an old sedative-hypnotic with anticancer activity?G Gasparini, A Morabito, E Magnani, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakiaG De Palo, U Veronesi, E Marubini, et al.

British Journal of Haematology|October 1, 1994

Cytosine arabinoside (Ara-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimensG Palmieri, A Morabito, A Rea, et al.

Pageof 33